CLINICAL_TRIALS
trial_result
· 2009-06-18
Clinical Trial Update: Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating Thalidomide for mucosa-associated lymphoid tissue lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Vienna | Conditions: MALT Lymphoma | Phase 2 | Status: COMPLETED